Isis Pharmaceutical
- ISIS
- NASDAQ
- Consumer Products
- Latest 23.08
- Currency US$
- Change 0.32
- Percent Change 1.406 %
- Volume 494,999
- Tue Jun 18, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
The Globe and Mail
Earnings & Estimates
Short Term
| Q1/11 | Q2/11 | Q3/11 | Q4/11 | Q1/12 | Q2/12 | Q3/12 | Q1/13 | Q2/13 | Q3/13 | |||
|
Actual quarterly earnings for the past eight quarters and estimated for the next two quarters |
||||||||||||
| Estimated EPS ($) | -0.19 | -0.21 | -0.21 | -0.19 | -0.25 | -0.07 | -0.28 | -0.03 | -0.27 | -0.31 | ||
| Actual EPS | -0.20 | -0.18 | -0.27 | -0.20 | -0.24 | -0.01 | -0.32 | -0.02 | -- | -- | ||
| Surprise (%) | -5.3 | 14.3 | -28.6 | -5.3 | 4.0 | 85.7 | -14.3 | 33.3 | -- | -- | ||
| Est. % Chg from Prior Year | -1.0 | 0.3 | -1.1 | -0.4 | -0.2 | 0.9 | -0.2 | 0.9 | -2,625.0 | 3.1 | ||
| {#} Analysts | 9 | 7 | 8 | 7 | 7 | 8 | 9 | 4 | 4 | 4 | ||
| Date of Earnings | May 05 | Aug 04 | Nov 07 | Feb 29 | May 08 | Aug 06 | Nov 06 | May 07 | Aug 05 | Nov 05 | ||
Data provided by Zacks Investment Research.
Long Term
| 2013 | 2014 | |||
|
Estimated annual earnings for the next |
||||
| Estimated EPS ($) | -0.79 | -0.89 | ||
| Actual EPS | -0.79 | -0.79 | ||
| Surprise (%) | -- | -- | ||
| Est. % Chg from Prior Year | -0.5 | -11.8 | ||
| {#} Analysts | 5 | 4 | ||
| Date of Earnings | -- | -- | ||
Trends & Revisions
Earnings Per Share Trend
| Current | 7-Days Ago | 30-Days Ago | 60-Days Ago | 90-Days Ago | |
| Mean | Mean | Mean | Mean | Mean | |
| Current Quarter (ends Jun 2013) | -0.27 | -0.27 | -0.30 | -0.32 | -0.34 |
| Next Quarter (ends Sep 2013) | -0.31 | -0.31 | -0.34 | -0.34 | -0.36 |
| Current Fiscal Year (ends Dec 2013) | -0.79 | -0.79 | -0.86 | -0.90 | -1.03 |
| Next Fiscal Year (ends Dec 2014) | -0.89 | -0.89 | -0.83 | -0.93 | -0.96 |
Data provided by Zacks Investment Research.
Earnings Revisions
| Last 7 Days | Last 30 Days | |||
| Up Revs | Down Revs | Up Revs | Down Revs | |
| 0 | 0 | 1 | 0 | |
| 0 | 0 | 1 | 0 | |
| 0 | 0 | 1 | 0 | |
| 0 | 0 | 0 | 1 | |